In patients with aggressive malignancies who are undergoing high-dose chemotherapy, even minimal elevation of troponin I (TnI) is associated with late left ventricular dysfunction. The time course of the subclinical myocardial damage and its impact on the clinical outcome have never been investigated previously.
Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy / D. Cardinale, M. T. Sandri, A. Colombo, N. Colombo, M. Boeri, G. Lamantia, M. Civelli, F. Peccatori, G. Martinelli, C. Fiorentini, C. M. Cipolla. - In: CIRCULATION. - ISSN 0009-7322. - 109:22(2004 Jun 08), pp. 2749-54-2754. [10.1161/01.CIR.0000130926.51766.CC]
Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy
C. Fiorentini;
2004
Abstract
In patients with aggressive malignancies who are undergoing high-dose chemotherapy, even minimal elevation of troponin I (TnI) is associated with late left ventricular dysfunction. The time course of the subclinical myocardial damage and its impact on the clinical outcome have never been investigated previously.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Prognostic Value of Troponin I.pdf
accesso solo dalla rete interna
Tipologia:
Publisher's version/PDF
Dimensione
375.14 kB
Formato
Adobe PDF
|
375.14 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
